MANUAL FOR NEWCASTLE MITOCHONDRIAL DISEASE SCALE …

Ataxia UK awarded a grant to employ a researcher for 18 months to do this proof-of-principle study testing a novel therapeutic approach in spinocerebellar ataxia type 1 (SCA1). Summary of the results. SCA1 is an inherited type of ataxia caused by the production of an abnormal form of the protein called ataxin-1 which is toxic to nerve cells. ................
................